Home / News / FAQ
FAQ

FAQ: HeartBeam and HeartNexus Partnership for Remote Cardiac Care

FaqStaq News - Just the FAQs • October 28, 2025
By FAQstaq Staff
Read Original Article →
FAQ: HeartBeam and HeartNexus Partnership for Remote Cardiac Care

Summary

HeartBeam Inc. has partnered with HeartNexus to provide 24/7 remote cardiology services using HeartBeam's patented 3D ECG technology. This collaboration enables patients to capture and transmit ECG recordings for immediate interpretation by board-certified cardiologists outside traditional medical facilities.

What is the main purpose of the HeartBeam and HeartNexus partnership?

The partnership enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional care settings, allowing immediate interpretation of ECG recordings by HeartNexus cardiologists.

How does HeartBeam’s technology work for remote cardiac monitoring?

Patients can capture a 30-second, cable-free ECG recording using HeartBeam’s patented 3D technology when symptoms occur, then transmit the data to HeartNexus cardiologists for immediate interpretation.

What makes HeartBeam’s ECG technology unique?

HeartBeam is creating the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing the signals into a 12-lead ECG, designed for portable use wherever the patient is located.

Who are the key organizations involved in this partnership?

HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac care, is partnering with HeartNexus Inc., a network of board-certified cardiologists specializing in cardiac test interpretation and telemedicine.

What regulatory approvals has HeartBeam’s technology received?

HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, while the 12-Lead ECG synthesis software is currently under FDA review.

What are the benefits of this remote cardiac monitoring solution?

The solution makes medical-grade cardiac monitoring accessible beyond medical facilities, allowing physicians to identify cardiac health trends and acute conditions while directing patients to appropriate care outside traditional settings.

What future developments are planned for HeartBeam’s ecosystem?

The partnership expands HeartBeam’s ecosystem with real-time cardiology feedback and future integration of AI wellness and wearable features to enhance cardiac health management.

Where can I find more information about HeartBeam and this partnership?

The full press release is available at https://ibn.fm/HqwuQ and the company’s newsroom is at https://ibn.fm/BEAT.

What intellectual property does HeartBeam hold for this technology?

HeartBeam holds over 20 issued patents related to technology enablement for their 3D ECG platform and cardiac monitoring solutions.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 267428